Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Grayson

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Epilepsy & Behavior Reports|April 24, 2020
A preliminary study of the effects of cannabidiol (CBD) on brain structure in patients with epilepsyAyushe A Sharma, Rodolphe Nenert, Jane B Allendorfer, et al.
Epilepsy & Behavior : E&B|March 5, 2021
Long-term safety and efficacy of highly purified cannabidiol for treatment refractory epilepsyTyler E Gaston, Steve B Ampah, E Martina Bebin, et al.
Epilepsy & Behavior : E&B|August 6, 2019
Drug-drug interactions with cannabidiol (CBD) appear to have no effect on treatment response in an open-label Expanded Access ProgramTyler E Gaston, E Martina Bebin, Gary R Cutter, et al.
Epilepsy & Behavior : E&B|September 2, 2020
Effects of highly purified cannabidiol (CBD) on fMRI of working memory in treatment-resistant epilepsyTyler E Gaston, Jane B Allendorfer, Sangeeta Nair, et al.
Epilepsy & Behavior : E&B|August 8, 2020
Cognitive function and adaptive skills after a one-year trial of cannabidiol (CBD) in a pediatric sample with treatment-resistant epilepsyMatthew D Thompson, Roy C Martin, Leslie P Grayson, et al.
The Journal of Clinical Investigation|November 7, 2001
Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemiaL Z He, T Tolentino, P Grayson, et al.
Comparative Biochemistry and Physiology. Part D, Genomics & Proteomics|April 7, 2023
Transcriptomic impacts and potential routes of detoxification in a lampricide-tolerant teleost exposed to TFM and niclosamideM J Lawrence, P Grayson, J D Jeffrey, et al.
Environmental Science & Technology|August 16, 2022
Variation in the Transcriptome Response and Detoxification Gene Diversity Drives Pesticide Tolerance in FishesM J Lawrence, P Grayson, J D Jeffrey, et al.
Comparative Biochemistry and Physiology. Part D, Genomics & Proteomics|September 2, 2023
Differences in the transcriptome response in the gills of sea lamprey acutely exposed to 3-trifluoromethyl-4-nitrophenol (TFM), niclosamide or a TFM:niclosamide mixtureM J Lawrence, P Grayson, J D Jeffrey, et al.
Journal of Clinical Psychology|September 25, 2025
Neurobehavioral Therapy Is Associated With Improvements in Social Functioning in Patients With Functional Seizures and Traumatic Brain InjuryRyan Van Patten, Erica Cotton, Lawrence Chan, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Epilepsy & Behavior Reports|April 24, 2020
A preliminary study of the effects of cannabidiol (CBD) on brain structure in patients with epilepsyAyushe A Sharma, Rodolphe Nenert, Jane B Allendorfer, et al.
Epilepsy & Behavior : E&B|March 5, 2021
Long-term safety and efficacy of highly purified cannabidiol for treatment refractory epilepsyTyler E Gaston, Steve B Ampah, E Martina Bebin, et al.
Epilepsy & Behavior : E&B|August 6, 2019
Drug-drug interactions with cannabidiol (CBD) appear to have no effect on treatment response in an open-label Expanded Access ProgramTyler E Gaston, E Martina Bebin, Gary R Cutter, et al.
Epilepsy & Behavior : E&B|September 2, 2020
Effects of highly purified cannabidiol (CBD) on fMRI of working memory in treatment-resistant epilepsyTyler E Gaston, Jane B Allendorfer, Sangeeta Nair, et al.
Epilepsy & Behavior : E&B|August 8, 2020
Cognitive function and adaptive skills after a one-year trial of cannabidiol (CBD) in a pediatric sample with treatment-resistant epilepsyMatthew D Thompson, Roy C Martin, Leslie P Grayson, et al.
The Journal of Clinical Investigation|November 7, 2001
Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemiaL Z He, T Tolentino, P Grayson, et al.
Comparative Biochemistry and Physiology. Part D, Genomics & Proteomics|April 7, 2023
Transcriptomic impacts and potential routes of detoxification in a lampricide-tolerant teleost exposed to TFM and niclosamideM J Lawrence, P Grayson, J D Jeffrey, et al.
Environmental Science & Technology|August 16, 2022
Variation in the Transcriptome Response and Detoxification Gene Diversity Drives Pesticide Tolerance in FishesM J Lawrence, P Grayson, J D Jeffrey, et al.
Comparative Biochemistry and Physiology. Part D, Genomics & Proteomics|September 2, 2023
Differences in the transcriptome response in the gills of sea lamprey acutely exposed to 3-trifluoromethyl-4-nitrophenol (TFM), niclosamide or a TFM:niclosamide mixtureM J Lawrence, P Grayson, J D Jeffrey, et al.
Journal of Clinical Psychology|September 25, 2025
Neurobehavioral Therapy Is Associated With Improvements in Social Functioning in Patients With Functional Seizures and Traumatic Brain InjuryRyan Van Patten, Erica Cotton, Lawrence Chan, et al.
Pageof 4